Revenue Performance - RCM Technologies reported revenue of $76.9 million for the thirteen weeks ended December 28, 2024, an increase of 8.3% compared to $71.0 million for the prior quarter[3] - For the fifty-two weeks ended December 28, 2024, revenue was $278.4 million, reflecting a 5.8% increase from $263.2 million in the prior year[4] - Revenue for the thirteen weeks ended December 28, 2024, was $76,912 million, an increase of 8.1% compared to $71,028 million for the same period in 2023[19] - For the fifty-two weeks ended December 28, 2024, total revenue reached $278,380 million, up from $263,237 million in the previous year, representing a growth of 5.8%[19] Profitability - GAAP net income for the current quarter was $2.9 million, or $0.37 per diluted share, down from $5.3 million, or $0.65 per diluted share, in the comparable prior quarter[3] - The company experienced a GAAP net income of $13.3 million, or $1.68 per diluted share, for the current year, compared to $16.8 million, or $1.96 per diluted share, for the prior year[4] - Adjusted net income per diluted share (non-GAAP) for the current year was $2.03, slightly down from $2.04 in the prior year[4] - Adjusted EBITDA for the current quarter was $6.3 million, compared to $8.9 million for the prior quarter[3] - The company reported a net income of $2,867 million for the thirteen weeks ended December 28, 2024, compared to $5,255 million for the same period in 2023[23] Expenses and Costs - Selling, general and administrative expenses increased to $16.0 million in the current quarter from $13.4 million in the prior quarter[3] - Gross profit for the current quarter was $21.6 million, consistent with the prior quarter's gross profit of $21.6 million[3] - The company’s gross profit for the fifty-two weeks ended December 28, 2024, was $79,778 million, compared to $76,696 million in the previous year[19] - Gross profit margin for the consolidated segment improved to 28.0% in Q4 2024 from 30.5% in Q4 2023[19] Assets and Liabilities - Total current assets increased to $97,038 million as of December 28, 2024, from $90,502 million a year earlier[21] - Cash and cash equivalents decreased to $4,729 million in Q4 2024 from $6,284 million in Q4 2023[21] - The company’s total liabilities rose to $98,593 million as of December 28, 2024, compared to $94,694 million in the previous year[21] - Stockholders' equity increased to $33,484 million as of December 28, 2024, from $25,790 million a year earlier[21] Future Outlook - The company plans to leverage its strategic initiatives to enhance earnings power in 2025[5] - RCM Technologies will host a conference call on March 13, 2025, to discuss these results[6] Cash Flow - Net cash used in operating activities for the thirteen weeks ended December 28, 2024, was $1,637 million, a decrease from $15,066 million in the same period of 2023[23]

Core Viewpoint - RCM Technologies, Inc. reported financial results for the thirteen and fifty-two weeks ended December 28, 2024, showing revenue growth but a decline in net income compared to the previous periods [2][3][4]. Financial Performance - For the thirteen weeks ended December 28, 2024, revenue was $76.9 million, an increase of 8.3% from $71.0 million in the prior quarter [2]. - Gross profit for the current quarter was $21.6 million, consistent with the prior quarter [2]. - GAAP net income for the current quarter was $2.9 million, or $0.37 per diluted share, down from $5.3 million, or $0.65 per diluted share, in the comparable prior quarter [2]. - Adjusted EBITDA for the current quarter was $6.3 million, compared to $8.9 million in the prior quarter [2]. - For the fifty-two weeks ended December 28, 2024, revenue was $278.4 million, a 5.8% increase from $263.2 million in the prior year [3]. - Gross profit for the current year was $79.8 million, a 4.0% increase from $76.7 million in the prior year [3]. - GAAP net income for the current year was $13.3 million, or $1.68 per diluted share, down from $16.8 million, or $1.96 per diluted share, in the prior year [3]. - Adjusted EBITDA for the current year was $25.9 million, compared to $26.6 million in the prior year [3]. Strategic Insights - Executive Chairman Bradley Vizi noted that 2024 demonstrated substantial progress as many strategic initiatives gained traction [4]. - CFO Kevin Miller expressed confidence in the foundation laid for increased earnings power in 2025 [4]. Revenue Breakdown - For the thirteen weeks ended December 28, 2024, revenue by segment was $41.0 million in Specialty Health Care, $26.3 million in Engineering, and $9.6 million in Life Sciences and Data Solutions [18]. - For the fifty-two weeks ended December 28, 2024, revenue by segment was $142.7 million in Specialty Health Care, $96.5 million in Engineering, and $39.2 million in Life Sciences and Data Solutions [18]. Balance Sheet Highlights - As of December 28, 2024, total assets were $132.1 million, up from $120.5 million a year earlier [20]. - Current assets increased to $97.0 million from $90.5 million [20]. - Total liabilities were $98.6 million, compared to $94.7 million in the prior year [20]. Cash Flow Analysis - For the thirteen weeks ended December 28, 2024, net cash used in operating activities was $(1.6) million, compared to $(15.1) million in the prior quarter [23]. - For the fifty-two weeks ended December 28, 2024, net cash provided by operating activities was $6.2 million, down from $12.5 million in the prior year [24].

Core Insights - 92% of healthcare leaders prioritize AI and advanced automation to address industry challenges, focusing on patient access and claim management for automation investments [1][4] Industry Trends - Rising administrative costs, increasing claim denials, payer conflicts, and cybersecurity threats are driving healthcare leaders to invest strategically in software that enhances cash flow and adapts to payer policies [2] - The top six trends for healthcare leaders in 2025 emphasize the importance of AI and advanced automation for improving efficiency, accuracy, and security [2] Investment Priorities - Key areas for RCM investment include patient access, claim management, revenue integrity, patient financial care, denial prevention, and denial management [4] - Return on investment (ROI) is a critical factor in RCM purchasing decisions, with many providers considering alternative vendors due to low ROI from current solutions [4] Data Security - Data security concerns rank as the second most important factor in switching RCM software, following negative client support experiences [4] Software Platform Preferences - Over 70% of providers now prefer working with one to two software partners for all RCM needs, moving away from multiple siloed solutions [4] - A 2024 study indicates that 100% of leaders using end-to-end software platforms report a positive ROI, highlighting the industry's shift towards integrated solutions [4] Patient Access and Claim Management - Hospitals spend nearly $20 billion annually to overturn denied claims, with 60% of denials stemming from front-end patient access errors, prompting increased automation in financial clearance processes [4] - Claim denials have increased by 20%, and labor costs for claims inquiries have risen by 71% over five years, leading providers to prioritize automation in claim management [4] Company Overview - Waystar serves approximately 30,000 clients, processing over 6 billion healthcare payment transactions annually, which includes over $1.8 trillion in gross claims [5]

Company Overview - RCM Technologies, Inc. has launched a new program to resell the UKG Ready suite, expanding its Human Capital Management (HCM) service offerings [1] - The company has established itself as a premier provider of business and technology solutions across various sectors, including Energy Services, Aerospace & Defense, and Health Care Services [5][8] Industry Context - There are over 33 million small businesses in the U.S., employing more than 61.6 million workers, indicating a significant demand for scalable and user-friendly HR solutions [2] - Small businesses often lack access to high-quality HCM solutions compared to larger enterprises, creating an opportunity for RCM to fill this gap [3] Product Offering - RCM's HCM Solutions provide immediate access to industry-leading technology, enabling small business owners to manage workforce needs efficiently while ensuring compliance and promoting growth [2][6] - The partnership with UKG Ready allows RCM to offer a comprehensive platform for payroll, time tracking, talent management, and employee engagement [6] Strategic Commitment - RCM's new reseller partnership with UKG emphasizes customer service, deep product expertise, and tailored workforce strategies, reinforcing its commitment to delivering top-tier HCM solutions [4] - The company aims to help small business owners streamline HR operations and focus on business growth [3][7]

Core Insights - RCM Thermal Kinetics has launched the New Ethanol eXpansion Technology (NEXT) program aimed at enhancing ethanol production capacity and energy efficiency without major equipment replacement [1][2][4] Industry Overview - International fuel ethanol consumption is expected to increase by 173% from 2021 to 2030, indicating a significant growth opportunity for ethanol producers [2] - The NEXT program allows existing ethanol plants to achieve over 20% additional production annually, translating to an increase of 20 million gallons for a plant producing 100 million gallons per year [2] Company Strategy - The NEXT program integrates strategic equipment upgrades and detailed hydraulic balance across critical systems, improving operational efficiency and profitability for ethanol producers [3] - The implementation of NEXT can occur during short-duration plant turnarounds, ensuring uninterrupted production schedules while providing a cost-effective expansion strategy [3][4] Environmental Impact - The NEXT program aligns with RCM Thermal Kinetics' mission to promote eco-conscious solutions in the biofuels industry, supporting both business success and environmental stewardship [4][5]

RCM Technologies, Inc. (RCMT) closed at $19.55 in the latest trading session, marking a +0.51% move from the prior day. The stock's change was less than the S&P 500's daily gain of 0.88%. On the other hand, the Dow registered a gain of 1.24%, and the technology-centric Nasdaq increased by 0.65%.Shares of the company have depreciated by 11.11% over the course of the past month, underperforming the Business Services sector's gain of 0.03% and the S&P 500's gain of 1.17%.Market participants will be closely fol ...

Staffing and consulting company RCM Technologies, Inc. (NASDAQ: RCMT ) had a run of vigorous growth during the COVID-19 crisis, fell back in late 2022 and the first half of 2023, then began bouncing back inRobert F. Abbott has been investing his family’s accounts since 1995, and in 2010 added options, mainly covered calls and collars with long stocks. He is a freelance writer, and his projects include a website that provides information for new and intermediate-level mutual fund investors. A resident of Air ...

For Immediate ReleasesChicago, IL – December 13, 2024 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include including RCM Technologies, Inc. (RCMT) , Datatec Ltd. (DTTLY) , EVERTEC, Inc. (EVTC) and Xperi Inc. (XPER) .Here are highlights from Friday’s Analyst Blog:4 Business Services Stocks You'll Regret Not Buying on Their D ...

Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their own strategies, so we are constantly looking at the latest trends in value, growth, and momentum to find strong companies for our readers.Considering these trends, value investing is clearly one of the most preferred ways to find strong stocks in any type of market. Value investors use tried-and-true metrics a ...

MURRAY, Utah, Nov. 19, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (“R1”), a leader in automating revenue management for healthcare providers, today announced that investment funds affiliated with TowerBrook Capital Partners (“TowerBrook”) and Clayton, Dubilier & Rice (“CD&R”) have completed their previously announced acquisition of R1. On August 1, 2024, TowerBrook, CD&R and R1 announced that they had entered into a definitive merger agreement under which all outstanding shares of R1 common stock that TowerBrook ...